COA Available
Nootropic In Stock Research Use Only
Cerebrolysin
60mg · Lyophilized Powder · Purity ≥98%
Cerebrolysin is a research-grade neuropeptide mixture preparation derived from standardised enzymatic breakdown of porcine brain protein, containing low-molecular-weight neuropeptides and amino acids studied in neuroprotection and neuroplasticity research. Supplied in 60mg format.
$35.99 CAD
Purchase Options
Subscriptions can be managed from your customer account. Prices in CAD.
Research Overview
Cerebrolysin is not a single peptide but a well-characterised neuropeptide mixture preparation produced through controlled enzymatic digestion of porcine brain tissue, yielding a complex of low-molecular-weight neuropeptides and free amino acids with neurotrophic and neuroprotective properties reported in preclinical research. It has been used as a research tool in investigations of BDNF-like neurotrophic signalling, synaptic plasticity, and neuronal survival pathways in ischemia and neurodegeneration models. BME Health supplies Cerebrolysin as a high-purity research preparation with full Certificate of Analysis documentation. Supplied exclusively for laboratory and research use.
Preclinical research has examined Cerebrolysin in models of cerebral ischemia, neurodegeneration, and age-related cognitive decline, with studies investigating its effects on markers of BDNF-like activity, synaptogenesis, and neuronal apoptosis in cell and animal preparations. Its heterogeneous composition — spanning multiple neuropeptide species — has made it a research tool for studying the combined effects of endogenous neuropeptide mixtures rather than single-compound mechanisms. Research has also probed its influence on neuroplasticity markers and neurotrophic factor signalling cascades in vitro. All outcomes referenced do not constitute evidence of clinical efficacy or safety in humans.
Specifications
| Compound | Cerebrolysin |
| Format | Lyophilized Powder |
| Size | 60mg |
| Purity (HPLC) | ≥98% |
| Item # | BME-CEREBR-A |
| Storage | −20°C, dry, dark |
| Price (CAD) | $35.99 |
COA / Testing
Batch documentation and third-party testing information are available for batch BME-CEREBR-A. COA previews appear only when documentation exists for the active batch.
Storage & Handling
Store Cerebrolysin research preparation at −20°C in a sealed container protected from light. As a complex neuropeptide mixture, it is particularly sensitive to thermal degradation; repeated freeze-thaw cycles should be strictly avoided to preserve the integrity of constituent peptide species. Vials should be inspected for integrity upon receipt, and any concerns reported to BME Health before commencing research preparations.
Shipping & Returns
Orders are processed on business days. Packaging is selected to maintain compound integrity in transit. Shipping timelines and return conditions are outlined in full in the Shipping & Returns policy — review before checkout if you have specific requirements. For orders with time-sensitive research schedules, contact support before placing your order.
Research Use Disclaimer
This product is supplied strictly for in-vitro and laboratory research use. It is not a drug, food supplement, or cosmetic and is not approved for human or veterinary clinical applications, diagnostics, or therapeutic use. Researchers are responsible for compliance with all applicable institutional and regulatory requirements in their jurisdiction.
Preparation Reference Guide
Research Solution Reference Calculator
Pre-filled with 60mg. Enter your solvent volume and target amount to see concentration and units on a U-100 syringe scale.
Concentration—
Volume to draw—
Syringe units (U-100)—
Per insulin unit—
For research-use calculations only. Always verify measurements independently — not medical guidance.
Questions before you order?
Browse the FAQ for documentation, storage, and sourcing answers, or contact our support team directly. We aim to respond to all research procurement inquiries within one business day.
Related
